90
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients

, , , &
Pages 602-603 | Received 03 Apr 2020, Accepted 13 May 2020, Published online: 01 Jun 2020

References

  • Hussain A, Tucker N, DeAngelis DD, et al. Guidelines for vismodegib in the management of periocular basal cell carcinoma. Can J Ophthalmol. 2019; pii: S0008-4182(19)30989-5. DOI:https://doi.org/10.1016/j.jcjo.2019.11.004
  • Scalvenzi M, Costa C, Cappello M, et al. Reply to Woltsche N. et al. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single-centre experience. J Eur Acad Dermatol Venereol. 2019;33(4):e145–e147.
  • Cox KF, Margo CE. Role of vismodegib in the management of advanced periocular basal cell carcinoma. Cancer Control. 2016;23(2):133–139.
  • Scalvenzi M, Villani A, Mazzella C, et al. Vismodegib treatment in a HIV positive patient on antiretroviral therapy. Indian J Dermatol Venereol Leprol. 2018;84(6):758–760.
  • Oliphant H, Laybourne J, Chan K, et al. Vismodegib for periocular basal cell carcinoma: an international multicentre case series. Eye (Lond). 2020. DOI:https://doi.org/10.1038/s41433-020-0778-3
  • Sagiv O, Nagarajan P, Ferrarotto R, et al. Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma. Br J Ophthalmol. 2019;103(6):775–780.
  • Wong KY, Fife K, Lear JT, et al. Vismodegib for locally advanced periocular and orbital basal cell carcinoma: a review of 15 consecutive cases. Plast Reconstr Sur Glob Open. 2017;5(7):e1424.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.